对于ICU终生决策的死亡率预测指标:delta-SOFA和SAPS 3 - 追溯评估
Maria Carmen Sala-Trull1, Pablo Monedero2, Francisco Guillen-Grima3,4
1Anaesthesia and Intensive Care, Clinica Universidad de Navarra, University of Navarra, Pamplona, Navarra, Spain csala@unav.es.
BMJ supportive & palliative care
|February 17, 2025
概括
通过将简化急性生理学得分3 (SAPS 3) 与顺序性器官衰竭评估 (SOFA) 得分的变化相结合,改善了重症监护室 (ICU) 的住院死亡率的预测. 这种方法,特别是在第五天使用delta-SOFA,有助于在长时间的ICU住院中做出复杂的终生决策.
科学领域:
- 关键护理医学 关键护理医学
- 预测模型的预测建模
- 健康 结果 研究 研究 结果
背景情况:
- 在ICU中生命终结的决定是复杂的,受患者状况,治疗有效性和资源可用性的影响.
- 准确预测住院死亡率对于指导这些决定至关重要.
研究的目的:
- 评估德尔塔-序列性器官衰竭评估 (SOFA) 在第二,第三和第五天对住院死亡率的分数的预测值.
- 评估delta-SOFA得分和简化急性生理学得分3 (SAPS3) 的综合预测能力.
主要方法:
- 对200名住院时间≥5天的ICU患者进行了回顾性队列研究 (2018-2020).
- 在录取和第二,第三和第五天收集SAPS 3和SOFA分数.
- 利用后勤回归和差异分析来识别死亡率预测因素并评估模型性能.
主要成果:
- 总体而言,住院死亡率为26%.
- 不幸存者表现出更高的SAPS 3分数和更糟糕的SOFA分数,特别是在第3天和第5天.
- 在第五天,SAPS 3和delta-SOFA的组合产生了0.71的AUROC,这表明预测准确度中等.
结论:
- 在第五天将delta-SOFA得分与SAPS 3结合起来,可以提高长期住院ICU期间住院死亡率的预测.
- 这些发现表明,早期治疗限制 (48小时内) 可能过早.
- 随着时间的推移,患者反应的演变支持对终身护理的更可行的共享决策.
更多相关视频
相关概念视频
Ethical Dilemmas II
903
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
903
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Actuarial Approach
54
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
54
Assumptions of Survival Analysis
84
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
84
Comparing the Survival Analysis of Two or More Groups
122
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
122
Kaplan-Meier Approach
79
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
79


